Biohealth Innovation
Click here to view original article »
 

You're receiving this newsletter because of your interest in BioHealth Innovation
Having trouble viewing this email? View it in your browser.

Sep 19, 2017
NEWS
 
ABOUT US PROGRAMS PARTNERS CLIENTS NEWS EVENTS CONTACT
 
NEWS
 
EVENTS
 
JOBS
 
 
 
Emergent BioSolutions Awarded $63 Million BARDA Contract to Develop Treatment for Cyanide Exposure

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract valued at approximately $63 million by the Biomedical Advanced Research and Development Authority (BARDA) to develop an antidote spray device for the treatment of known or suspected acute cyanide poisoning. The single-use intranasal spray device will deliver a stabilized form of isoamyl nitrite (SIAN) and is intended for use by first responders and medical personnel following a cyanide incident.

READ MORE
 
 
 
 
ConverGene Announces Sponsored Research Agreement with University of Maryland, Baltimore to Evaluate First-in-class Anti-cancer Agents

ConverGene has entered into a Sponsored Research Agreement with University of Maryland, Baltimore. Under this agreement University of Maryland School of Medicine Professor Curt I. Civin, M.D., who is associate dean for research and director of the Center For Stem Cell Biology & Regenerative Medicine, will investigate the in vivo anti-leukemic effects of ConverGene’s lead drug candidates, CG223 and CG250. Acute Myelogenous Leukemia (AML) is a likely first disease target for these compounds.

READ MORE
RightEye: This startup eyes billions-dollar market - Washington Business Journal

The company just received a Series A investment from VSP Global, one of the country’s largest networks of vision doctors.

READ MORE
Producing cures, Emergent BioSolutions works to protect people around the world - Longform story

Threats come in all sizes, some so small you can't see. The damage, however can be catastrophic.

Emergent BioSolutions creates remedies for diseases like cancer and ebola, chemical attacks like anthrax, as well as those against our troops, like mustard gas.

READ MORE
Qiagen, Angle to Comarket Liquid Biopsy Technologies | GenomeWeb

UK-based liquid biopsy firm Angle said today that it has inked a comarketing agreement with Qiagen for circulating tumor cell (CTC) technology.

READ MORE
Shuttle Pharmaceuticals and POLA Pharma Inc. Agree to License U.S. Rights to Doranidazole

Shuttle Pharmaceuticals, Inc. (USA) and POLA Pharma Inc. (Japan), today announced agreement to license the U.S. rights for doranidazole, a hypoxic cell radiation sensitizer, for clinical development in treating cancers in combination with stereotactic body radiation therapy (SBRT). SBRT is used to deliver large doses of radiation in a few treatments with precise targeting of cancers. Current radiation dose limitations, due to sensitive normal tissues that may surround a tumor, support a role for radiation sensitizers to enhance the effectiveness of radiation. Clinical trials to determination safety and efficacy of the combination of doranidazole and SBRT are proposed for treating patients with pancreatic, lung and liver cancers.

READ MORE
Why Children’s National Medical Center is hosting a Silicon Valley symposium - Washington Business Journal

After holding it in the District for years, the health system is packing up and taking its annual symposium across the country.

READ MORE
Maryland firm acquires Johns Hopkins startup Fractal Technology - Technical.ly Baltimore

Fractal Technology, a startup founded at Johns Hopkins, was recently acquired by Annapolis Junction–based Sunayu, according to the cofounders.

READ MORE
Hopkins, Maryland, UMBC ranked among top colleges by U.S. News and World Report - Baltimore Sun

The Johns Hopkins University and the University of Maryland, College Park were ranked among the top tier in the U.S. News and World Report annual rankings of colleges and universities released Tuesday.

READ MORE
What Does It Cost to Create a Cancer Drug? Less Than You’d Think - The New York Times

What does it really cost to bring a drug to market?

The question is central to the debate over rising health care costs and appropriate drug pricing. President Trump campaigned on promises to lower the costs of drugs.

READ MORE
FDA Grants “Fast Track” Status to Cancer Prevention Pharmaceuticals’ Lead Drug CPP-1X/sul for Treatment of Familial Adenomatous Polyposis | Business Wire

Cancer Prevention Pharmaceuticals, Inc. (CPP), a private biotech company developing novel therapeutics to prevent cancer and other diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted “Fast-Track” status for its lead drug CPP-1X/sul for adults with familial adenomatous polyposis (FAP), which is currently in a Phase 3 clinical trial. FAP is a rare genetic disease that if left untreated progresses to colorectal cancer in nearly 100% of patients. Currently there is no effective treatment for FAP.

READ MORE
Montgomery County Trying To Lure Amazon - Bethesda Beat - Bethesda, MD

The greatest economic development sweepstakes in the country is underway and Montgomery County officials are hoping the county can be a player.

Amazon is searching for a second headquarters site to house as many as 50,000 employees, at an expected cost of $5 billion to construct. The footprint for the new headquarters would be up to 8 million square feet by 2027 and an initial 500,000 square feet by 2019.

READ MORE
Greater Washington reacts to Inova CEO Knox Singleton's retirement - Washington Business Journal

When Knox Singleton first took the helm at Inova Health System in 1984, Mobil Corp. was still building its campus — the first major corporate headquarters ever landed by Fairfax County — on the massive wooded lot just across the street from the health system's Fairfax hospital.

READ MORE
Life Sciences Venture Capital Firm Flagship Pioneering to Raise $500M Fund

Flagship Pioneering (fka Flagship Ventures), a Cambridge, MA-based life sciences venture capital firm, is seeking to raise $500m for its latest fund.

READ MORE
Congress rejects Trump proposals to cut health research funds - American Pharmacists Association

Congressional lawmakers from both parties have rejected the Trump administration's proposals to cut spending for NIH, and have joined forces to increase spending on biomedical research.

READ MORE
New York City is positioning itself as a life sciences hub | Building Design + Construction

Developers Taconic Investment Partners and Silverstein Properties are spending $20 million to renovate the 326,861-sf Movie Lab building in Midtown Manhattan for life science research usage.

READ MORE
Welcome to Cellacon Valley? - Philadelphia Magazine

In the conference room of a spacious loft office near 30th Street Station, Usman “Oz” Azam and Michael Christiano huddle for a meeting. They’re CEO and chief business officer, respectively, of Tmunity Therapeutics, a start-up launched to commercialize some breakthrough research out of the University of Pennsylvania — a method of reengineering a patient’s own immune system cells so they can destroy cancer tumors.

READ MORE
TISSUEGENE RECOGNIZED DURING MARYLAND COMMERCE, STATE DEPARTMENTS’ WEEK-LONG TRADE MISSION TO SOUTH KOREA

A trade and diplomatic mission to South Korea led by officials from the Maryland Department of Commerce and the Maryland Secretary of State’s office concluded the evening of Friday, September 8, 2017, with a reception at the U.S. Ambassador to South Korea’s residence in Seoul.

READ MORE
Request for Proposal: Real Estate Consultant Services to Develop and Evaluate Developer Proposals

The Pinkney Innovation Complex for Science and Technology is located on the Montgomery College Germantown Campus. We're also known as PIC MC. The College is ideally situated in Montgomery County, Maryland, within the Washington, DC metropolitan region.

The area is home to more than 350 bioscience companies and key federal institutions, including the National Institutes of Health, the Food and Drug Administration, the National Institute of Standards and Technology, and the Walter Reed Army Institute for Research.

Surrounded by woodlands, the site provides immediate access to the I-270 technology corridor. The park is currently being developed to accommodate life sciences, cybersecurity, and other technology companies.

READ MORE
 
 
 
 

EVENTS

 
 
 
Australia- Great Opportunity for Defense Contractors
Sep 18
EAGB Breakfast Series- Leading the Cyber Transformation
Sep 19
5th Annual Pediatric Device Innovation Symposium
Sep 24
Women Building Bio: The XX Factor
Sep 26
   
 

Home | About BHI | BHI News | Programs | Partners | Contact
Copyright © BioHealth Innovation 2012
All Rights Reserved. 
22 Baltimore Road Rockville, MD 20850
Subscribe

 
 
The information contained in this website and newsletters is for general information purposes only. The information is provided by BioHealth Innovation via its newsletters, but not written or endorsed in any way by BioHealth Innovation unless otherwise noted. While we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.